benzoxazoles has been researched along with HbS Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, AD; Eitzman, DT; Guo, C; Harro, D; Tran, J; Wang, H; Wang, J | 1 |
1 other study(ies) available for benzoxazoles and HbS Disease
| Article | Year |
|---|---|
mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.
Topics: Anemia; Anemia, Sickle Cell; Animals; Benzoxazoles; Disease Models, Animal; Erythrocytes; Hematocrit; Hemoglobins; Mice; Pyrimidines; Sirolimus; Splenomegaly; TOR Serine-Threonine Kinases | 2016 |